The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Speaker, Faculty, Planners and Authors Conflict of Interest Disclosure: Speaker(s) have no disclosures to declare.
Planning Committee: • Annette Hood discloses that she is a member of the Amgen speakers’ bureau. • Denise Murcek discloses other financial/material support as an employee of the VA Medical Center. • Elizabeth St. John discloses other financial/material support as an employee of Fresenius Medical Care. • Kyra Trappett discloses other financial/material support as an employee of DaVita.
Commercial Support and Sponsorship: Supported by an educational donation from Amgen.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives: • Discuss hemoglobin variability and its effect on patient outcomes in ESRD patients. • Develop a comprehensive knowledge base of the pharmacodynamics of longer acting ESA agents. • Recognize unit, nursing, and patient factors that may benefit from the implementation of longer acting ESA agents.
Speaker(s):
Christine
M. Chmielewski,
MS, CRNP, ANP-BC, CNN-NP,
Nephrology Nurse Practitioner,
Thomas Jefferson University Hospital
Jennifer
Payton,
MHCA, BSN, RN, CNN,
Surveyor,
National Dialysis Accreditation Commission
You must be logged in and own this session in order to
post comments.
